Abstract. Dictyostelium discoideum expresses a developmentally regulated cell surface glycoprotein of Mr 80,000 (gp80), which has been implicated in the formation of the EDTA-resistant contact sites A at the cell aggregation stage. To determine whether gp80 participates directly in cell binding and, if so, its mode of action, we conjugated purified gp80 to Covaspheres (Covalent Technology Corp., Ann Arbor, MI) and investigated their ability to bind to cells. The binding of gp80-Covaspheres was dependent on the developmental stage of the cells, with maximal interaction at the late aggregation stage. Scanning electron microscopic studies revealed the clustering of gp80-Covaspheres at the polar ends of these cells, similar to the pattern of gp80 distribution on the cell surface as reported earlier (Choi, A. H. C., and Siu, C.-H., 1987, J. Cell Biol., 104:1375-1387. Precoating cells with an adhesion-blocking anti-gp80 monoclonal antibody inhibited the binding of gp80-Covaspheres, suggesting that Covasphere-associated gp80 might undergo homophilic interaction with gp80 on the cell surface. Quantitative binding of ~25I-labeled gp80 to intact cells gave an estimate of 1.5 x 105 binding sites per cell at the aggregation stage. Binding of soluble gp80 to cells was blocked by precoating cells with the anti-gp80 monoclonal antibody. The ability of gp80 to undergo homophilic interaction was further tested in a filterbinding assay, which showed that t25I-labeled gp80 was able to interact with gp80 bound on nitrocellulose in a dosage-dependent manner. In addition, reassociation of cells was significantly inhibited in the presence of soluble gp80, suggesting that gp80 has a single cellbinding site. These results are consistent with the notion that gp80 mediates cell-cell binding at the aggregation stage of developmet via homophilic interaction.
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I
NTERCELLULAR cohesion plays a vital role in the morphogenesis and development of the cellular slime mold Dictyostelium discoideum. At the onset of development, EDTA-sensitive-binding sites are expressed rapidly on the cell surface. At 5-6 h of development, cells begin to acquire a sensitivity to extracellular cAMP and undergo chemotactic migration towards areas of higher cAMP concentration (20) . At this stage, cells express a number of new antigenic determinants on the cell surface (32) (33) (34) and an increase in cell cohesiveness (27) . New ceil-cell-binding sites that are resistant to EDTA dissociation begin to appear on the cell surface. These binding sites were first defined serologically by Gerisch and co-workers (1, 2) and were named contact sites A. Beug et al. (2) prepared polyclonal antibodies against aggregation-stage cells. After absorption against vegetative cells, Fab fragments derived from these antibodies are capable of inhibiting contact sites A. Subsequently, they found that the inhibitory effect of the Fab fragments can be neutralized by a highly enriched membrane glycoprotein of Mr 80,000 (gp80) ~ (24) . Since gp80 contains some highly im-munogenic carbohydrate moieties, several polyclonal antisera developed against gp80 that can inhibit cell cohesion, show cross-reactivity with other gtycoproteins (17, 25, 31) . Therefore, it has been enigmatic whether gp80 is actually involved in cell cohesion. To resolve this issue, we have raised a large number of monoclonal antibodies directed against gpS0. One of them, 80L5C4, was monospecific for gpS0 and it is also capable of blocking the EDTA-resistant contact sites A (31). It is, therefore, very likely that gp80 is directly involved in cell cohesion.
The role of gp80 in cell cohesion is apparently stage specific, since the monoclonal antibody 80L5C4 inhibits the EDTA-resistant binding sites only at the aggregation stage and its effect diminishes rapidly afterwards (31) . Synthesis of gp80 occurs only for a discrete period corresponding closely to the expression ot contact sites A (16, 25) . The amount of gp80 begins to decrease after completion of cell mound formation (25, 26, 31) . These observations indicate that gp80 is playing a transient, though crucial, role in cell cohesion during development.
It has been suggested that contact sites A might be involved in the formation of end-to-end contacts among cells (13) . Cells at the aggregation stage are more elongated and the cell surface expresses a large number of filopodia, which are characteristic of early migrating cells (8) . Surface localiza-tion by immunufluorescence labeling or immunoelectron microscopy reveals a biased distribution of gp80 on these cells (4) . gp80 molecules are more abundantly localized at the two polar ends of cells and on the filopodia, suggesting that they are important in mediating the formation of end-to-end contacts between cells.
Although it is evident that gp80 plays an important role in 
Materials and Methods

Cell Strain and Culture Conditions
The wild type strain NC4 of Dictyostelium discoideum was used in all experiments and the axenic strain AX2 was used for the purification of gp80. NC4 cells were cultured in association with Klebsiella aerogenes and were developed as described (39) . Growth phase cells were collected from the partially cleared bacterial lawn, washed free of bacteria, and plated at 2 x 108 ceils/ml on filter paper (No. 50; Whatman, Inc., Clifton, NJ) for development. Under these conditions, ceils began to aggregate between 6 and 8 h and aggregation was completed by 12 h with the formation of round mounds. Culmination began at 'M8 h. Alternatively, cells were resuspended at 107 cells/ml in 17 mM phosphate buffer, pH 6.4, and shaken at 180 rpm for development. The axenic strain AX2 was cultured in HL-5 medium as described by Cocucci and Sussman (5) . Cells were collected in their late exponential growth phase and developed in 17 mM phosphate buffer, pH 6.4, for 12 h, with cAMP pulsing (2 x 10 -8 M final concentration) at 7-min intervals.
Purification of gp80
gpg0 was purified from AX2 cells after 12 h of development in liquid culture. Cells were collected and homogenized. The particulate fraction was solubilized with 1% sodium cholate and 0.2% NP-40 in PBS. The sample was centrifuged at 100,000 g for 60 min and the soluble fraction was decanted and diluted with PBS at 1:1 ratio. The sample was loaded on to a concanavalin A (Con A) column and bound glycoproteins were eluted with 0.1 M ~tmethy-mannoside in 0.1% NP--40 or 0.1% Triton X-100. Fractions were pooled and dialyzed before being chromatograpbed on a DEAEcellulose column, equilibrated in 10 mM sodium acetate, pH 5.5, 0.5 mM EDTA, and 0.1% Triton X-100. The column was eluted with a linear gradient of 0 to 150 mM NaCI. Fractions enriched in gp80 were pooled, and dialyzed, and then absorbed onto an affinity column prepared by coupling 80L5C4 IgG to CNBr-activated Sepharose 4B (Pharmacia, Inc., Piscataway, NJ). The bound protein was eluted with 50 mM diethylamine, pH 11.3. Protein fractions were neutralized immediately and dialyzed against PBS or 0.1% cctyl glucoside in PBS. Purity of the gp80 sample was evaluated by silver staining (23) after electrophoretic separation in polyacrylamide gel (15) . Homogeneity was achieved usually by one passage through the immunoaffinity column. Purified gpg0 was stored either in lyophilized form or in solution at -70*C.
Coupling of gp80 to Covaspheres
Green or red MX Covaspheres (approximately 0.5 gm in diameter) were obtained from Covalent Technology Corp. (Ann Arbor, MI). Cooaspheres were first sonicated for 1 min to disperse the aggregates and then 10 Ixg of purified gp80 was added to 0.1 ml of Cooaspheres. The final volume was adjusted to 0.2 or 0.3 ml with PBS. The mixture was incubated on a rotator for 75 min at room temperature and the Covaspheres were pelleted by centrifugation. The supernate was discarded and the pellet was resuspended in 1 ml of 1% BSA in PBS by brief sonication. This was repeated once and the gpg0-conjugated Covaspheres were stored in suspension in 0.2 ml of 1% BSA at 4"C. Coupling of Con A, BSA, or protein A to Covaspheres was carried out using the same procedure. 
Binding of gp80-Covaspheres to Cells
Scanning Electron Microscopy (SEM)
Cells were deposited on cooer glass with 0.1% poly-L-lysine (Sigma Chemical Co., St. Louis, MO) (22) . After 8-10 h of development, cells were incubated with gp80-Cooaspheres for 10 rain on a platform shaker rotated at 60 rpm. Unbound Covaspheres were quickly rinsed off and cells were fixed with 2% glutaraldehyde for 30 min at room temperature. Subsequent steps of dehydration and critical point drying were carded out as previously described (4). Samples were observed with a Jeol JSM 840 scanning electron microscope.
Binding of gp80 to Intact Cells
Immunoaffinity-purified gp80 was dialyzed against 0.1% octyl glucoside in PBS. gp80 was radioiodinated using the chloramine T method as previously described (32) . Different concentrations of mI-labeled gpg0 were prepared in phosphate buffer immediately before addition to cell suspension, with a final detergent concentration not exceeding 0.005 %. Cells were resuspended in 10 mM EDTA and 17 mM phosphate buffer, pH 6.4, at 2-5 x 106 cells/ ml. Incubation was carried out at 4~ for 45 min on a platform shaker. Cell samples were layered on top of 0.3 ml of an oil mixture containing bis-(2-ethylhexyl)-phthalate and n-bntyl phthalate (1:1.2, vol/vol), and then centrifuged to separate the unbound gpg0 from the cells. The cell pellet was counted in a gamma counter and the amount of gp80 bound was estimated. The amount of nonspecifically bound gp80 was estimated by including a 40-fold higher concentration of unlabeled gp80 in the incubation mixture. This value was subtracted from the total amount of radioactivity bound to cells.
Competition of gp80 Binding to Cells by Monoclonal Antibody
Cells were resuspended at 2 x l07 cells/ml in 17 mM phosphate buffer, pH 6.4, containing 5 mM EDTA and then precoated with 80L5C4 IgG (31) at 10 gg/rnl for 15 rain at 4~ Cells were washed once and resuspended at 5 • 106 cells/ml in EDTA/phosphate buffer containing 0.25 mg/ml goat anti-mouse IgG Fab (Cappel Laboratories, Inc., Cochranville, PA) for 15 min at 4~ The sample was briefly vortexed before the addition of gp80-Covaspheres or labeled gp80. Subsequent steps were carried out in accordance with the corresponding assay protocol.
Filter-binding Assay
gp80 samples were spotaxt on to nitrocellulose disks, which were blocked with 5% skim milk in PBS and 0.05% Tween-20 and then incubated with different amounts of mI-labeled gp80 for 30 rain at room temperature. A blank disk was included in each sample for background estimation. At the end of the incubation period, disks were washed with at least three changes of
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5 % skim milk followed by two changes of 0.05 % Twcen-20 in PBS. Disks were air dried and counted in a gamma counter. In competition experiments, nitrocellulose disks were preincubated with different amounts of unlabeled gp80 for 5 rain before the addition of a constant amount of labeled gp80. Binding was carded out for another 30 min. Disks were washed and processed for counting.
Cell Cohesion Assay
Cell-cell adhesion was assayed as described previously (31) . Cells were dissociated and suspended at 2-3 x 106 cells/ml in 17 mM phosphate buffer, pH 6.4, with 5 mM EDTA. Samples were rotated vertically on a platform shaker at 180 rpm. Cells were counted at different time intervals using a hemacytometer. Both singlets and doublets were scored as unaggregated cells.
Results
Binding of gp80-conjugated Covaspheres to Cells
Immunoaffinity-purified gp80 was analyzed by gel electrophoresis followed by silver staining. Fig. 1 shows that no detectable contaminating components were present in the sample. The gp80 preparation was considered pure and was used for conjugation to Covaspheres. gp80-Covaspheres were sonicated to disperse aggregates before use. NC4 cells at 12 h of development were dissociated into single cells and then resuspended in phosphate buffer containing 5 mM EDTA. The appropriate amout of gp80-Covaspheres was II Cells were precoated with g0L5C4 IgG at 10 Ixg/ml for t5 min and then resuspended in goat anti-mouse lgG Fab (0.2 mg/ml) and 5 mM EDTA. The cells was briefly vortexed and then allowed to bind with either gpS0--Covaspheres or Con A-Covaspheres at 4~ 82 gpg0-Covaspheres weldi gested with trypsin at 0.1 mg/rnl for 15 rain at 37"C and the reaction was terminated by the addition of an equivalent amount of trypsin inhibitor. The spheres were washed twice with phosphate buffer before being used in the binding assay. ** gpS0-Covaspheres were preeoated with 80L5C4 Fab at 0.5 mg/ml for 30 min at room temperature and the unbound Fab was removed before being used in the binding assay.
added and the sample was rotated on a platform shaker at 4~ About 40% of the cells reformed small aggregates after 20 min of incubation. By that time, a large number of gp80-Covaspheres had bound to the cell aggregates (Fig. 2,  a and b) . In the control experiment, cells were mixed with BSA-conjugated Covaspheres and a maximum of two to three Covaspheres per aggregate was observed (Fig. 2 d) . Therefore, nonspecific trapping of Covaspheres in cell aggregates appeared to be minimal.
To quantitate the binding of Covaspheres to cells, samples were subjected to analysis in a cell sorter. Cell particles were divided into two categories, single cells and aggregates, and the percentage of cell particles that carried fluoresceinlabeled spheres was estimated. The proportion of cell panicles with bound gp80--Covaspheres was almost five times higher than the control using BSA-Covaspheres in the single cell category and more than three times higher in the aggregate category (Table I) . As an additional negative control, protein A was conjugated to Covaspheres and allowed to bind to 12-h cells. The percentage of cells with bound Covaspheres was similar to the BSA control (Table I ). In both controis, cell aggregates appeared to trap Covaspheres more easily. As a positive control, the binding of Con A-conju-
with bound Con A-Covaspheres was comparable to the case of gp80-Covaspheres, gp80-Covaspheres did not bind significantly to 0-h cells (Table I) .
Homophilic Binding of gpSO
To determine whether gp80 binds homophilically to gp80 molecules on the cell or heterophilically to other surface receptor(s), 12-h cells were precoated with the monoclonal antibody 80L5C4, which blocked the cell-binding site of gp80 (32) . The cells were further coated with goat antimouse IgG Fab and then incubated with gp80-Covaspheres. Fig. 2 c shows (Table I) . As a control, cells with or without precoating with 80L5C4 IgG and the second univalent antibody were allowed to bind Con A-Covaspheres. About 60% of cell panicles contained Con A-Covaspheres in both cases (Table I) . To demonstrate that the binding of Covaspheres to cells was dependent on gp80, gpS0-Covaspheres were treated with trypsin before the binding assay. Results in Table I show that the binding of trypsinized gpS0-Covaspheres to cells dropped to background level. When gpS0-Covaspheres were pretreated with 80L5C4 Fab, binding of Covaspheres to cells was also blocked (Table I) . These results suggest that the gp80 conjugated on Covaspheres binds homophilically to the cell surface gp80 and that the binding is dependent on the availability of the cellbinding site on gp80.
Localization of gp80-C ovaspheres by SEM
We have previously shown that gp80 is preferentially localized at the two polar ends of the elongated migration-stage cell (4). It is, therefore, expected that the binding of gp80-Covaspheres to these cells should reflect the physiological distribution of gp80 on the cell surface. To test this, cells were developed on polylysine-coated coverslips and gp80-Covaspheres were added to the medium at the midaggregation stage for 10 min to allow interaction with the migrating cells. Samples were immediately fixed and processed for SEM. gp80-Covaspheres showed a clearly biased distribution on the cell surface. Covaspheres appeared to cluster mainly at the polar ends of these elongated cells (Fig. 3, a and b) . They were also observed on lamellipodia as well as filopodia (Fig. 3, c and d) . The control using BSACovaspheres showed only sparse binding while the binding of Con A-Covaspheres to the cell surface had a random distribution (data not shown).
Stage-specific Binding of gp80-Covaspheres to Cells
Since the expression of gpS0 is developmentally regulated (25, 31) , the binding of gp80-Covaspheres to cells in the developmental cycle should reflect stage specificity corresponding to the time of gp80 appearance on the cell surface. To investigate this, cells were developed for different time periods and collected for binding studies. Fig. 4 shows that gp80-Covaspheres did not bind significantly to vegetative rapidly between 6 and 9 h of development, corresponding to the time when gp80 is known to be actively synthesized in the cell (17, 25) . At 18 h, the number of cells with Covaspheres dropped by ,x,50%.
Binding of l~I-Labeled gp80 to Intact Cells
The binding of gp80 to cells was also carried out using ~25I-labeled gp80. Since gp80 formed aggregates in solution, gp80 prepared in detergent-free buffer bound to cells poorly and results were often inconsistent. When samples were dialyzed against 0.1% octyl glucoside before use, gp80 molecules were capable of binding to cells. Cells were incubated with the ~25I-labeled gp80 for 45 min on a platform shaker. The assay was carried out at 4~ in the presence of 10 mM EDTA to slow down the kinetics of cell reassociation. Under these conditions, usually <40% of the cells formed small aggregates at the end of the incubation period, thus minimizing nonspecific trapping of gp80. Usually between 80 and 90% of the total bound tzSI-gp80 could be competed off by preincubation with a 40-fold concentration of unlabeled gp80. Fig, 5 shows that the binding of ~25I-labeled gp80 to cells was both dosage dependent and saturable. The number of gp80-binding sites on the cell surface was estimated to be "~1.5 • 1@ sites/cell. In addition, the binding of t25I-labeled gp80 to 3-h cells was only at background level, indicating stage specificity of the binding reaction (Fig. 5 a) . The effect of precoating cells with the anti-gp80 monoclonal antibody 80L5C4 was also examined. The binding of ~25I-labeled gp80 to cells was inhibited in a dosagedependent manner (Fig. 5 b) . These results are consistent with the notion that the soluble gp80 binds homophilically with the membrane-bound gp80 of aggregation-stage cells.
gp80-mediated Aggregation of Covaspheres
In the cell-binding experiment using gp80-Covaspheres, we noted that small aggregates of gp80-Covaspheres began to appear after 60 min of incubation on a platform shaker. The aggregation of gp80-Covaspheres was further investigated. Covaspheres conjugated with gp80 or protein A were first sonicated to disperse all aggregates (Fig. 6 a) and then gyrated on a platform shaker at 200 rpm and samples were observed under the fluorescence microscope at regular intervals. Large aggregates of gp80-Covaspheres were observed at 90 min (Fig. 6 b) , while protein A-Covaspheres and BSA-Covaspheres did not show any significant degree of self-aggregation under similar conditions (data not shown). When gp80-Covaspheres were rotated in the presence of soluble gp80, self-association was inhibited (Fig. 6 c) . The data clearly indicate that the reassociation of gp80-Covaspheres was mediated by homophilic interaction of the gp80 molecules conjugated on these spheres. To further demonstrate that the reassociation of gp80-Covaspheres was dependent on the cell-binding site of gp80 molecules, gp80-Covaspheres were rotated in the presence of Fab fragments derived from 80L5C4 IgG. Reassociation of gp80-Covaspheres was completely abolished (Fig. 6 d) . When the sample was examined after 90 min, 3 and 15 h of rotation, the gp80-Covaspheres remained as single particles.
Binding of xz~I-Labeled gp80 to Filter-bound gp80
The interaction of gp80 with gp80 was also studied using an in vitro filter-binding assay. Unlabeled gp80 was immobilized on nitrocellulose membrane and incubated with ~zsI-labeled gp80. Quantitative binding between the soluble gp80 and the immobilized gp80 was analyzed. Fig. 7 shows the dosage-dependent-binding curve of gpS0-gpS0 interaction. At the saturation level, ~,1 mol of immobilized gp80 bound 0.2 mol of soluble gp80, suggesting that the binding of gp80 to nitrocellulose probably rendered 80 % of the gp80-binding sites unavailable for interaction. To demonstrate the binding specificity, competition experiments were carried out. Inclusion of a 50-fold higher concentration of unlabeled gp80 reduced the binding of L2q-labeled gp80 to nitrocellulosebound gp80 by ~80% (Fig. 7 B) .
Effect of Soluble gp80 on CeU-CeU Binding
If solubilized gp80 exists in monomeric form and each monomer contains only one cell-binding site, binding of soluble gp80 to cells should block cell-ceU adhesion mediated by the homophilic interaction of membrane-associated gp80 molecules. Such an experiment was performed with aggregation-stage cells, gp80 was dialyzed in 0.1% octyl glucoside and then added to cells to give a final detergent concentration of 0.005 %. The mixture was vortexed for 10 s to dissociate cells and the reassociation of cells was monitored under microscope at regular intervals. Cell reassociation was significantly inhibited in the presence of soluble gp80 during the first 45 min of incubation, while cells incubated in the presence of an equivalent amount of octyl glucoside showed the normal kinetics of reassociation (Fig.  8 A) . Cells reassociated in the presence of soluble gp80 formed only small aggregates (Fig. 9) . The inhibitory effect of gp80 was dosage dependent (Fig. 8 B) . At 10 ~g/ml of gp80, ,x~60% of the cells failed to form aggregates and the effect was halved at 5 I~g/ml. The effect of soluble gp80 be- came negligible at a concentration of 0.1 Ixg/ml. Generally, after 60 min of incubation, cells began to reassociate into larger aggregates even in the presence of 10 ttg/ml of soluble gpS0. By 120 min, the degree of reassociation was indistinguishable from that of the control (Fig. 8 A) . It is likely that some of the gp80 molecules in solution began to aggregate on the cell surface as a result of the much reduced detergent concentration and this eventually led to the cross-linking of cells.
Discussion
In this report, results of several different assays clearly demonstrate that purified gp80 is capable of binding specifically to D. discoideum ceils at the aggregation stage of development. Purified gp80, when conjugated to Covaspheres, can mediate the binding of these spheres to cells in a stagespecific manner, gp80 has a tendency to aggregate in the absence of detergent and it does not bind to surface receptors in a consistent manner. However, prior treatment with a mild detergent allows gp80 to interact with surface components. Of several detergents we have tried, octyl glucoside has the least deleterious effect on cells.
Cells precoated with the anti-gp80 monoclonal antibody 80L5C fail to bind soluble gp80 or gp80-Covaspheres ( spheres to cells is also inhibited (Table I) . These results clearly indicate that the interaction of cells with Covaspheres is dependent on the gp80-binding site, and they are consistent with the idea that gp80 molecules undergo homophilic interaction. However, it is inherent in studies using monoclonal antibodies as blocking agents that the results do not usually rule out the possibility of nonspecific steric hindrance. In this case, one can argue that gpS0 receptors are closely associated with gp80 molecules on the cell surface and the binding of 80L5C4 IgG to gp80 sterically blocks the accessibility of the receptors binding site. Two in vitro assays have been developed to resolve this issue. The first assay addresses the question whether Covaspheres conjugated with gp80 can undergo self-association, gpS0-Covaspheres are found to reassociate into small aggregates within a short period of time after dispersion. This self-association can be abolished by the inclusion of 80L5C4 Fab in the sample (Fig.  6 ). In the filter-binding assay, labeled gp80 binds to nitrocellulose-bound gp80 quantitatively and in a saturable manner. The bindng can be competed off specifically by unlabeled gp80 (Fig. 7) . These results thus indicate that purified gp80 is capable of undergoing homophilic interaction. It is likely that gp80 behaves in the same manner in vivo. Since the monoclonal antibody 80L5C4 inhibits the binding of soluble gp80 to cells, gpS0-Covasphere aggregation, and gp80-gp80 interaction at concentrations similar to those required for the disruption of cell-cell contact formation, it suggests that the same gp80-binding site is involved in both in vivo and in vitro assays. Moreover, when dispersed cells are incubated in the presence of soluble gp80, cell re.aggregation is drastically reduced. This result clearly supports the mechanism of homophilic interaction and it also indicates that each gp80 molecule has a single cell-binding site.
It is of interest to note that gp80 and the neuronal cell adhesion molecule (N-CAM) share a number of similarities. They are both involved in the calcium-independent type of cell-cell binding (3) . N-CAM also behaves as a ligand in cell-cell adhesion (28) . The N-CAM-binding site is located in the amino terminus of the polypeptide chain (6, 7, 11) . N-CAM is heavily glycosylated and its embryonic form contains a large amount of sialic acid, resulting in a highly negatively charged molecule (14) . The carbohydrate moieties, located primarily in the middle portion of the molecule, are probably not directly involved in cell-cell binding, although the affinity of N-CAM to N-CAM interaction is apparently modulated by the sialic acid (I0). gp80 is also glycosylated, containing at least two types of carbohydrate side-chains, one of which is heavily sulfated (37) . Although it has been suggested that the carbohydrate moiety of gp80 may play a role in cell-cell binding (21, 31, 35) , it remains to be determined whether it is directly involved in cell binding. Fig. 10 depicts three possible models for gp80-gp80 interaction. Since the cell-binding activity of gp80 is disrupted by 80L5C4, which recognizes a peptide epitope (31); gp80-gp80 binding can be mediated by homophilic interaction of the protein-binding site (Fig. 10 A) . In this case, carbohydrate moieties do not participate in the binding mechanism, but it may modulate the binding affinity as in the case of N-CAM (10). The second model depicts a carbohydrate-protein-interacting site in addition to the protein-protein binding site (Fig. 10 B) . This should accommodate the finding that certain antibodies recognizing oligosaccharides also interfere with cell-cell adhesion (31, 35) . The third model suggests that gp80 acts as a lectin and its own carbohydrate sidechain serves as the ligand. Since precoating cells or Covaspheres with 80L5C4 Fab disrupts the adhesive interaction, this model would require that gp80 from both surfaces are allowed to bind with its ligand to achieve stable binding (Fig.  10 C) . Future studies on the gp80-binding site should help us determine the precise components involved and the molecular nature of the homophilic interaction.
The role of gp80 in cell cohesion is unique to the aggrega- 
